Technical Analysis for ANTX - AN2 Therapeutics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 2.28 | -5.00% | -0.12 |
ANTX closed down 5.0 percent on Thursday, April 25, 2024, on 43 percent of normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: May 8
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing Low | Bearish | 0.00% | |
| New 52 Week Low | Weakness | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| NR7 | Range Contraction | -5.00% | |
| Narrow Range Bar | Range Contraction | -5.00% | |
| Wide Bands | Range Expansion | -5.00% | |
| Oversold Stochastic | Weakness | -5.00% | |
| Narrow Range Bar | Range Contraction | -3.80% | |
| Doji - Bullish? | Reversal | -3.80% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakdown | about 10 hours ago |
| New 52 Week Low | about 10 hours ago |
| Down 3% | about 15 hours ago |
| Fell Below Previous Day's Low | about 15 hours ago |
| Down 2 % | about 15 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/08/2024
AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menlo Park, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Infectious Diseases Microbiology Tuberculosis Bacteriology Nontuberculous Mycobacteria Serious Infectious Diseases
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Infectious Diseases Microbiology Tuberculosis Bacteriology Nontuberculous Mycobacteria Serious Infectious Diseases
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 22.15 |
| 52 Week Low | 2.28 |
| Average Volume | 420,561 |
| 200-Day Moving Average | 12.16 |
| 50-Day Moving Average | 3.02 |
| 20-Day Moving Average | 2.83 |
| 10-Day Moving Average | 2.45 |
| Average True Range | 0.23 |
| RSI (14) | 24.81 |
| ADX | 42.38 |
| +DI | 12.83 |
| -DI | 37.30 |
| Chandelier Exit (Long, 3 ATRs) | 3.20 |
| Chandelier Exit (Short, 3 ATRs) | 2.96 |
| Upper Bollinger Bands | 3.68 |
| Lower Bollinger Band | 1.98 |
| Percent B (%b) | 0.18 |
| BandWidth | 60.32 |
| MACD Line | -0.53 |
| MACD Signal Line | -0.61 |
| MACD Histogram | 0.0845 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 2.46 | ||||
| Resistance 3 (R3) | 2.48 | 2.44 | 2.43 | ||
| Resistance 2 (R2) | 2.44 | 2.39 | 2.43 | 2.42 | |
| Resistance 1 (R1) | 2.36 | 2.37 | 2.34 | 2.34 | 2.41 |
| Pivot Point | 2.32 | 2.32 | 2.31 | 2.31 | 2.32 |
| Support 1 (S1) | 2.24 | 2.27 | 2.22 | 2.22 | 2.15 |
| Support 2 (S2) | 2.20 | 2.25 | 2.19 | 2.14 | |
| Support 3 (S3) | 2.12 | 2.20 | 2.13 | ||
| Support 4 (S4) | 2.10 |
